文献速递类风湿关节炎

跖骨间滑囊炎:早期类风湿关节炎关节旁炎症的新特征及其与临床体征的关联

Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-07-16

OBJECTIVE: Intermetatarsal bursae in the forefeet possess a synovial lining similar to joints and tendon sheaths. Inflammation of these bursae (intermetatarsal bursitis [IMB]) was recently identified as specific for early rheumatoid arthritis (RA).…

要点

  • 早期RA患者中69%存在跖骨间滑囊炎,与滑膜炎和腱鞘炎独立相关。
  • 跖骨间滑囊炎与局部关节肿胀和压痛独立相关,不受RAMRIS炎症影响。
  • DMARD治疗后跖骨间滑囊炎大小随炎症减轻而缩小,ACPA亚组结果一致。

核心结论

  • 跖骨间滑囊炎伴随关节和腱鞘滑膜炎症,对DMARD治疗反应相似,并与典型临床体征相关,提示其为早期RA常见的关节旁滑膜炎症新特征。

主要发现

  • 69%的RA患者存在至少1个跖骨间滑囊炎。
  • 滑囊水平多变量分析显示,跖骨间滑囊炎与局部滑膜炎(OR 1.69,95%CI 1.12–2.57)和腱鞘炎(OR 2.83,95%CI 1.80–4.44)独立相关,与骨炎无关。
  • 患者水平跖骨间滑囊炎与腱鞘炎关联最强(OR 2.92,95%CI 1.62–5.24)。
  • 跖骨间滑囊炎与局部关节肿胀(OR 2.7,95%CI 1.3–5.3)和压痛(OR 1.7,95%CI 1.04–2.9)独立于RAMRIS炎症相关。
  • 治疗期间跖骨间滑囊炎大小在0至12个月间减小,与RAMRIS炎症下降相关,后者由滑膜炎减轻驱动;ACPA阳性和阴性RA结果相似。

关键数值与推荐

  • 跖骨间滑囊炎存在定义为MRI显示至少1个跖骨间滑囊炎。
  • 滑膜炎、腱鞘炎和骨炎按RA MRI评分系统(RAMRIS)评估并汇总为RAMRIS炎症。

临床怎么用

  • 早期RA评估中应关注跖骨间滑囊炎,其与临床肿胀压痛相关,可作为关节旁炎症的影像学标志。
  • 跖骨间滑囊炎对DMARD治疗有反应,随访MRI可监测其变化。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intermetatarsal bursae in the forefeet possess a synovial lining similar to joints and tendon sheaths. Inflammation of these bursae (intermetatarsal bursitis [IMB]) was recently identified as specific for early rheumatoid arthritis (RA). The present study was undertaken to determine if IMB is indeed an RA feature by assessing the following: 1) the association with other local inflammatory measures (synovitis, tenosynovitis, and osteitis), 2) the association with clinical signs, and 3) whether it responds to disease-modifying antirheumatic drug (DMARD) therapy similarly to other local inflammatory measures. METHODS: One hundred fifty-seven consecutive early RA patients underwent unilateral contrast-enhanced 1.5T forefoot magnetic resonance imaging (MRI) at diagnosis. MRIs were evaluated for IMB presence and for synovitis, tenosynovitis, and osteitis in line with the RA MRI Scoring (RAMRIS) system (summed as RAMRIS inflammation). MRIs at 4, 12, and 24 months were evaluated for IMB presence and size in patients who had IMB at baseline and received early DMARD therapy. Logistic regression and generalized estimating equations were used. Anti-citrullinated protein antibody (ACPA) stratification was performed. RESULTS: Sixty-nine percent of RA patients had ≥1 IMB. In multivariable analysis on bursa level, presence of IMB was independently associated with local presence of synovitis and tenosynovitis, with odds ratios (OR) of 1.69 (95% confidence interval [95% CI] 1.12, 2.57) and 2.83 (95% CI 1.80, 4.44), respectively, but not osteitis. On the patient level, IMB presence was most strongly associated with tenosynovitis (OR 2.92 [95% CI 1.62, 5.24]). IMB presence was associated with local joint swelling (OR 2.7 [95% CI 1.3, 5.3]) and tenderness (OR 1.7 [95% CI 1.04, 2.9]) independent of RAMRIS inflammation. During treatment, IMB size decreased between 0 and 12 months. This decrease associated with decrease in RAMRIS inflammation, which was driven by synovitis decrease. Within ACPA-positive and ACPA-negative RA, similar results were obtained. CONCLUSION: IMB particularly accompanies inflammation of the synovial lining of joints and tendon sheaths, showed a similar treatment response after DMARD initiation, and associates with typical clinical signs. These findings suggest that IMB represents a frequently present novel RA feature of juxtaarticular synovial inflammation.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. van Dijk BT, Dakkak YJ, Matthijssen XME, et al. Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study. Arthritis Care Res (Hoboken). 2022. PMID: 33973415. doi:10.1002/acr.24640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。